Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1971 2
1972 2
1973 1
1974 1
1976 3
1978 1
1979 2
1980 6
1981 4
1982 7
1983 12
1984 18
1985 24
1986 32
1987 67
1988 60
1989 73
1990 84
1991 120
1992 126
1993 147
1994 167
1995 168
1996 173
1997 215
1998 173
1999 153
2000 186
2001 170
2002 134
2003 151
2004 177
2005 211
2006 237
2007 243
2008 248
2009 297
2010 331
2011 449
2012 420
2013 572
2014 532
2015 500
2016 500
2017 440
2018 509
2019 538
2020 598
2021 668
2022 602
2023 510
2024 198

Text availability

Article attribute

Article type

Publication date

Search Results

10,220 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Immunodeficiency 25"
Page 1
Therapeutic options for CTLA-4 insufficiency.
Egg D, Rump IC, Mitsuiki N, Rojas-Restrepo J, Maccari ME, Schwab C, Gabrysch A, Warnatz K, Goldacker S, Patiño V, Wolff D, Okada S, Hayakawa S, Shikama Y, Kanda K, Imai K, Sotomatsu M, Kuwashima M, Kamiya T, Morio T, Matsumoto K, Mori T, Yoshimoto Y, Dybedal I, Kanariou M, Kucuk ZY, Chapdelaine H, Petruzelkova L, Lorenz HM, Sullivan KE, Heimall J, Moutschen M, Litzman J, Recher M, Albert MH, Hauck F, Seneviratne S, Pachlopnik Schmid J, Kolios A, Unglik G, Klemann C, Snapper S, Giulino-Roth L, Svaton M, Platt CD, Hambleton S, Neth O, Gosse G, Reinsch S, Holzinger D, Kim YJ, Bakhtiar S, Atschekzei F, Schmidt R, Sogkas G, Chandrakasan S, Rae W, Derfalvi B, Marquart HV, Ozen A, Kiykim A, Karakoc-Aydiner E, Králíčková P, de Bree G, Kiritsi D, Seidel MG, Kobbe R, Dantzer J, Alsina L, Armangue T, Lougaris V, Agyeman P, Nyström S, Buchbinder D, Arkwright PD, Grimbacher B. Egg D, et al. J Allergy Clin Immunol. 2022 Feb;149(2):736-746. doi: 10.1016/j.jaci.2021.04.039. Epub 2021 Jun 7. J Allergy Clin Immunol. 2022. PMID: 34111452 Free article.
Immunoglobulin replacement was effective in prevention of infection. Only 4 of 16 patients (25%) with cytopenia who underwent splenectomy had a sustained clinical response. ...
Immunoglobulin replacement was effective in prevention of infection. Only 4 of 16 patients (25%) with cytopenia who underwent splenec …
British Lung Foundation/United Kingdom Primary Immunodeficiency Network Consensus Statement on the Definition, Diagnosis, and Management of Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders.
Hurst JR, Verma N, Lowe D, Baxendale HE, Jolles S, Kelleher P, Longhurst HJ, Patel SY, Renzoni EA, Sander CR, Avery GR, Babar JL, Buckland MS, Burns S, Egner W, Gompels MM, Gordins P, Haddock JA, Hart SP, Hayman GR, Herriot R, Hoyles RK, Huissoon AP, Jacob J, Nicholson AG, Rassl DM, Sargur RB, Savic S, Seneviratne SL, Sheaff M, Vaitla PM, Walters GI, Whitehouse JL, Wright PA, Condliffe AM. Hurst JR, et al. J Allergy Clin Immunol Pract. 2017 Jul-Aug;5(4):938-945. doi: 10.1016/j.jaip.2017.01.021. Epub 2017 Mar 25. J Allergy Clin Immunol Pract. 2017. PMID: 28351785 Free article. Review.
A proportion of people living with common variable immunodeficiency disorders develop granulomatous-lymphocytic interstitial lung disease (GLILD). ...There was no consensus on whether expectant management following optimization of immunoglobulin therapy was acceptable: 67% …
A proportion of people living with common variable immunodeficiency disorders develop granulomatous-lymphocytic interstitial lung dis …
The prevalence of depression among adolescent with HIV/AIDS: a systematic review and meta-analysis.
Ayano G, Demelash S, Abraha M, Tsegay L. Ayano G, et al. AIDS Res Ther. 2021 Apr 27;18(1):23. doi: 10.1186/s12981-021-00351-1. AIDS Res Ther. 2021. PMID: 33906698 Free PMC article. Review.
The prevalence was highest amongst female adolescents (32.15%) than males (25.07%) as well as amongst the older adolescents aged 15-19 years (37.09%) than younger adolescents aged 10-14 years (29.82%). ...
The prevalence was highest amongst female adolescents (32.15%) than males (25.07%) as well as amongst the older adolescents aged 15-1 …
Clinical, Immunological, and Genetic Features in Patients with Activated PI3Kδ Syndrome (APDS): a Systematic Review.
Jamee M, Moniri S, Zaki-Dizaji M, Olbrich P, Yazdani R, Jadidi-Niaragh F, Aghamahdi F, Abolhassani H, Condliffe AM, Aghamohammadi A, Azizi G. Jamee M, et al. Clin Rev Allergy Immunol. 2020 Dec;59(3):323-333. doi: 10.1007/s12016-019-08738-9. Clin Rev Allergy Immunol. 2020. PMID: 31111319
A total of 243 APDS patients were identified from 55 articles. For all patients, demographic, clinical, immunologic, and molecular data were collected. Overall, 179 APDS1 and 64 APDS2 patients were identified. ...The predominant immunologic phenotype was hyper-IgM s …
A total of 243 APDS patients were identified from 55 articles. For all patients, demographic, clinical, immunologic, and molecular da …
Cutaneous manifestations of genodermatoses and primary immunodeficiency.
Lewis DJ, Wu JH, Boyd M, Duvic M, Feldman SR. Lewis DJ, et al. Dermatol Online J. 2019 Jun 15;25(6):13030/qt1gj1n07j. Dermatol Online J. 2019. PMID: 31329384 Free article. Review.
Immunodeficiency is most commonly related to inherited syndromes, infections, chemotherapy, or aging. ...In this review, we discuss a number of cutaneous findings associated with primary immunodeficiencies. Awareness of these cutaneous associations may aid in …
Immunodeficiency is most commonly related to inherited syndromes, infections, chemotherapy, or aging. ...In this review, we di …
Persistent SARS-CoV-2 PCR Positivity Despite Anti-viral Treatment in Immunodeficient Patients.
Chan M, Linn MMN, O'Hagan T, Guerra-Assunção JA, Lackenby A, Workman S, Dacre A, Burns SO, Breuer J, Hart J, Tadros S, Lowe DM. Chan M, et al. J Clin Immunol. 2023 Aug;43(6):1083-1092. doi: 10.1007/s10875-023-01504-9. Epub 2023 May 6. J Clin Immunol. 2023. PMID: 37148422 Free PMC article.
Of the 32/103 patients where sustained clearance was not confirmed, 6 died (between 2 and 34 days from treatment). Notably, we observed 25 cases of sputum positivity despite negative nasopharyngeal swab samples, as well as recurrence of SARS-CoV-2 positivity following a ne …
Of the 32/103 patients where sustained clearance was not confirmed, 6 died (between 2 and 34 days from treatment). Notably, we observed 2 …
Nijmegen breakage syndrome (NBS).
Chrzanowska KH, Gregorek H, Dembowska-Bagińska B, Kalina MA, Digweed M. Chrzanowska KH, et al. Orphanet J Rare Dis. 2012 Feb 28;7:13. doi: 10.1186/1750-1172-7-13. Orphanet J Rare Dis. 2012. PMID: 22373003 Free PMC article. Review.
Laboratory findings include: (1) spontaneous chromosomal breakage in peripheral T lymphocytes with rearrangements preferentially involving chromosomes 7 and 14, (2) sensitivity to ionizing radiation or radiomimetics as demonstrated in vitro by cytogenetic methods or by colony sur …
Laboratory findings include: (1) spontaneous chromosomal breakage in peripheral T lymphocytes with rearrangements preferentially involving c …
The European Society for Immunodeficiencies (ESID) Registry Working Definitions for the Clinical Diagnosis of Inborn Errors of Immunity.
Seidel MG, Kindle G, Gathmann B, Quinti I, Buckland M, van Montfrans J, Scheible R, Rusch S, Gasteiger LM, Grimbacher B, Mahlaoui N, Ehl S; ESID Registry Working Party and collaborators. Seidel MG, et al. J Allergy Clin Immunol Pract. 2019 Jul-Aug;7(6):1763-1770. doi: 10.1016/j.jaip.2019.02.004. Epub 2019 Feb 15. J Allergy Clin Immunol Pract. 2019. PMID: 30776527
They help to achieve a sufficient sample size for epidemiological and clinical research and to assess the feasibility of clinical trials. The European Society for Immunodeficiencies (ESID) registry currently comprises information on more than 25,000 patients with in …
They help to achieve a sufficient sample size for epidemiological and clinical research and to assess the feasibility of clinical trials. Th …
HIV Epidemic in Libya: Identifying Gaps.
Hamidi A, Regmi PR, van Teijlingen E. Hamidi A, et al. J Int Assoc Provid AIDS Care. 2021 Jan-Dec;20:23259582211053964. doi: 10.1177/23259582211053964. J Int Assoc Provid AIDS Care. 2021. PMID: 34841956 Free PMC article. Review.
BACKGROUND: HIV (human immunodeficiency virus) and AIDS (acquired immunodeficiency syndrome) became a public issue in Libya after the infection of 400 children in El-Fatih Hospital in 1988. ...Primary research studies and official reports that are exclusively on Lib …
BACKGROUND: HIV (human immunodeficiency virus) and AIDS (acquired immunodeficiency syndrome) became a public issue in Libya af …
Characteristics and Outcomes of Anti-interferon Gamma Antibody-Associated Adult Onset Immunodeficiency.
Zhang B, Fan J, Huang C, Fan H, Chen J, Huang X, Zeng X. Zhang B, et al. J Clin Immunol. 2023 Oct;43(7):1660-1670. doi: 10.1007/s10875-023-01537-0. Epub 2023 Jun 26. J Clin Immunol. 2023. PMID: 37365453 Free PMC article.
PURPOSE: Anti-interferon gamma antibody (AIGA) is a rare cause of adult onset immunodeficiency, leading to severe disseminated opportunistic infections with varying outcomes. ...In the multivariate logistic analysis, skin involvement, NTM infection, and recurrent infection …
PURPOSE: Anti-interferon gamma antibody (AIGA) is a rare cause of adult onset immunodeficiency, leading to severe disseminated opport …
10,220 results
You have reached the last available page of results. Please see the User Guide for more information.